RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Omonike Olaleye to Humans

This is a "connection" page, showing publications Omonike Olaleye has written about Humans.
Connection Strength

0.579
  1. Onyenaka C, Idowu KA, Ha NP, Graviss EA, Olaleye OA. Anti-Tuberculosis Potential of OJT008 against Active and Multi-Drug-Resistant Mycobacterium Tuberculosis: In Silico and In Vitro Inhibition of Methionine Aminopeptidase. Int J Mol Sci. 2023 Dec 05; 24(24).
    View in: PubMed
    Score: 0.046
  2. Egbejimi A, Ajewole V, Dongarwar D, Kaur M, Phillips M, Liang J, Fadel M, Lota L, Simon J, Otule M, Taylor K, Oguibe G, Salihu HM, Olaleye O. Racial Disparities in Preterm Birth among Pregnant Women with Obesity. South Med J. 2023 06; 116(6):471-477.
    View in: PubMed
    Score: 0.045
  3. Olaleye OA, Zash R, Diseko M, Mayondi G, Mabuta J, Lockman S, Melton ML, Mmalane M, Makhema J, Shapiro RL. Impact of prophylactic antimalarials in pregnant women living with Human Immunodeficiency Virus?on birth outcomes in Botswana. Trop Med Int Health. 2022 11; 27(11):990-998.
    View in: PubMed
    Score: 0.043
  4. Tavera G, Dongarwar D, Salemi JL, Akindela O, Osazuwa I, Akpan EB, Okolie U, Johnson M, Spooner KK, Akpan UI, Yusuf KK, Chukwudum C, Salihu HM, Olaleye OA. Diabetes in pregnancy and risk of near-miss, maternal mortality and foetal outcomes in the USA: a retrospective cross-sectional analysis. J Public Health (Oxf). 2022 08 25; 44(3):549-557.
    View in: PubMed
    Score: 0.042
  5. Olaleye OA, Dongarwar D, Salihu HM, Adu-Gyamfi S, Kaur M, Egbejimi A, Moerchen VA, Belcher HME, Holmes F, Kuo A, Copeland-Linder N, Noble CA, Vamos CA, Waters CR, Brown CM, Reddy MM. HRSA-Funded MCH Pipeline Training Program: Advancing the MCH Pipeline and Workforce Through Research Collaborations. Matern Child Health J. 2022 Aug; 26(Suppl 1):147-155.
    View in: PubMed
    Score: 0.042
  6. Kehinde IA, Egbejimi A, Kaur M, Onyenaka C, Adebusuyi T, Olaleye OA. Inhibitory mechanism of Ambroxol and Bromhexine Hydrochlorides as potent blockers of molecular interaction between SARS-CoV-2 spike protein and human angiotensin-converting Enzyme-2. J Mol Graph Model. 2022 07; 114:108201.
    View in: PubMed
    Score: 0.041
  7. Kehinde IA, Egbeyemi A, Kaur M, Onyenaka C, Adebusuyi T, Olaleye OA. Inhibitory mechanism of clioquinol and its derivatives at the exopeptidase site of human angiotensin-converting enzyme-2 and receptor binding domain of SARS-CoV-2 viral spike. J Biomol Struct Dyn. 2023 04; 41(7):2992-3001.
    View in: PubMed
    Score: 0.041
  8. Thompson J, Onyenaka C, Oduguwa E, Dongarwar D, Gendra S, Coker V, Kutse S, Blanco M, Nwangwu O, King C, Enamorado E, Bakare O, Ajewole VB, Spooner KK, Salemi JL, Aliyu MH, Salihu HM, Olaleye OA. Trends and Racial/Ethnic Disparities in the Rates of Pre-eclampsia by HIV Status in the US. J Racial Ethn Health Disparities. 2021 06; 8(3):670-677.
    View in: PubMed
    Score: 0.037
  9. Salihu H, Dongarwar D, Ikedionwu CA, Shelton A, Jenkins CM, Onyenaka C, Charles C, Wang H, Osemene I, Harris KJ, Kaur M, Rasmus M, Awosemo O, Milton S, Estill S, Adebusuyi T, Gao X, Mbye YFN, Chen Y, Olaleye OA. Racial/Ethnic Disparities in the Burden of HIV/Cervical Cancer Comorbidity and Related In-hospital Mortality in the USA. J Racial Ethn Health Disparities. 2021 02; 8(1):24-32.
    View in: PubMed
    Score: 0.036
  10. John SF, Aniemeke E, Ha NP, Chong CR, Gu P, Zhou J, Zhang Y, Graviss EA, Liu JO, Olaleye OA. Characterization of 2-hydroxy-1-naphthaldehyde isonicotinoyl hydrazone as a novel inhibitor of methionine aminopeptidases from Mycobacterium tuberculosis. Tuberculosis (Edinb). 2016 12; 101S:S73-S77.
    View in: PubMed
    Score: 0.028
  11. Olaleye O, Raghunand TR, Bhat S, Chong C, Gu P, Zhou J, Zhang Y, Bishai WR, Liu JO. Characterization of clioquinol and analogues as novel inhibitors of methionine aminopeptidases from Mycobacterium tuberculosis. Tuberculosis (Edinb). 2011 Dec; 91 Suppl 1:S61-5.
    View in: PubMed
    Score: 0.020
  12. Olaleye O, Raghunand TR, Bhat S, He J, Tyagi S, Lamichhane G, Gu P, Zhou J, Zhang Y, Grosset J, Bishai WR, Liu JO. Methionine aminopeptidases from Mycobacterium tuberculosis as novel antimycobacterial targets. Chem Biol. 2010 Jan 29; 17(1):86-97.
    View in: PubMed
    Score: 0.018
  13. Olaleye OA, Bishai WR, Liu JO. Targeting the role of N-terminal methionine processing enzymes in Mycobacterium tuberculosis. Tuberculosis (Edinb). 2009 Dec; 89 Suppl 1:S55-9.
    View in: PubMed
    Score: 0.018
  14. Fernandes P, Wang K, Timmerman J, Reyes A, Holmes F, Olaleye OA, Salihu HM, Moerchen VA, Belcher HME, Copeland-Linder N, Noble CA, Vamos CA, Armstrong A, Waters CR, Long-White D, Brown C, Reddy MM, Kuo A. Success of Maternal and Child Health Pipeline Training Programs: Alumni Survey Results. Matern Child Health J. 2022 Aug; 26(Suppl 1):69-77.
    View in: PubMed
    Score: 0.011
  15. Belcher HME, Copeland-Linder N, Stone J, Waters CR, Kuo A, Moerchen V, Olaleye O, Salihu HM, Vamos C, Brown C, Reddy MM. MCH Pipeline Training Program: Connecting with Academia to Build Capacity Through Mentoring. Matern Child Health J. 2022 Aug; 26(Suppl 1):37-43.
    View in: PubMed
    Score: 0.010
  16. Fernandes P, Wang K, Timmerman J, Reyes A, Holmes F, Olaleye OA, Salihu HM, Moerchen VA, Belcher HME, Copeland-Linder N, Noble CA, Vamos CA, Armstrong A, Waters CR, Long-White D, Brown C, Reddy MM, Kuo A. Success of Maternal and Child Health Pipeline Training Programs: Alumni Survey Results. Matern Child Health J. 2022 Jul; 26(7):1415-1423.
    View in: PubMed
    Score: 0.010
  17. Darlington F, Acha BM, Roshan T, Ikeanyionwu C, Kutse S, Abajue U, Osazuwa B, Gomez I, Spooner KK, Salemi JL, Dongarwar D, Olaleye OA, Salihu HM, Ndefo UA. Opioid-Related Disorders Among Pregnant Women with Sickle Cell Disease and Adverse Pregnancy Outcomes. Pain Med. 2020 11 01; 21(11):3087-3093.
    View in: PubMed
    Score: 0.009
  18. Dongarwar D, Taylor J, Ajewole V, Anene N, Omoyele O, Ogba C, Oluwatoba A, Giger D, Thuy A, Argueta E, Naik E, Salemi JL, Spooner K, Olaleye O, Salihu HM. Trends in Appendicitis Among Pregnant Women, the Risk for Cardiac Arrest, and Maternal-Fetal Mortality. World J Surg. 2020 Dec; 44(12):3999-4005.
    View in: PubMed
    Score: 0.009
  19. Nguyen NH, Le EN, Mbah VO, Welsh EB, Daas R, Spooner KK, Salemi JL, Olaleye OA, Salihu HM. Opioid Use Among HIV-Positive Pregnant Women and the Risk for Maternal-Fetal Complications. South Med J. 2020 06; 113(6):292-297.
    View in: PubMed
    Score: 0.009
  20. Ekpenyong O, Gao X, Ma J, Cooper C, Nguyen L, Olaleye OA, Liang D, Xie H. Pre-Clinical Pharmacokinetics, Tissue Distribution and Physicochemical Studies of CLBQ14, a Novel Methionine Aminopeptidase Inhibitor for the Treatment of Infectious Diseases. Drug Des Devel Ther. 2020; 14:1263-1277.
    View in: PubMed
    Score: 0.009
  21. Erwin ER, Addison AP, John SF, Olaleye OA, Rosell RC. Pharmacokinetics of isoniazid: The good, the bad, and the alternatives. Tuberculosis (Edinb). 2019 05; 116S:S66-S70.
    View in: PubMed
    Score: 0.008
  22. Salihu HM, Henshaw C, Salemi JL, Dongarwar D, Wudil UJ, Olaleye O, Godbole N, Aggarwal A, Aliyu MH. Temporal trends and black-white disparity in mortality among hospitalized persons living with HIV in the United States. Medicine (Baltimore). 2019 Mar; 98(9):e14584.
    View in: PubMed
    Score: 0.008
  23. Dennis EM, Hao Y, Tamambang M, Roshan TN, Gatlin KJ, Bghigh H, Ogunyemi OT, Diallo F, Spooner KK, Salemi JL, Olaleye OA, Khan KZ, Aliyu MH, Salihu HM. Tuberculosis during pregnancy in the United States: Racial/ethnic disparities in pregnancy complications and in-hospital death. PLoS One. 2018; 13(3):e0194836.
    View in: PubMed
    Score: 0.008
  24. Prophet J, Kelly K, Domingo J, Ayeni H, Mekouguem XPD, Dockery B, Allam F, Kaur M, Artis J, Spooner KK, Salemi JL, Olaleye OA, Salihu HM. Severe pre-eclampsia among pregnant women with sickle cell disease and HIV. Pregnancy Hypertens. 2018 Jan; 11:87-91.
    View in: PubMed
    Score: 0.008
  25. Fernandez D, Salami I, Davis J, Mbah F, Kazeem A, Ash A, Babino J, Carter L, Salemi JL, Spooner KK, Olaleye OA, Salihu HM. HIV-TB Coinfection among 57 Million Pregnant Women, Obstetric Complications, Alcohol Use, Drug Abuse, and Depression. J Pregnancy. 2018; 2018:5896901.
    View in: PubMed
    Score: 0.008
  26. Falana A, Akpojiyovwi V, Sey E, Akpaffiong A, Agumbah O, Chienye S, Banks J, Jones E, Spooner KK, Salemi JL, Olaleye OA, Onyiego SD, Salihu HM. Hospital length of stay and cost burden of HIV, tuberculosis, and HIV-tuberculosis coinfection among pregnant women in the United States. Am J Infect Control. 2018 05; 46(5):564-570.
    View in: PubMed
    Score: 0.008
  27. Vijayakumar S, Finney John S, Nusbaum RJ, Ferguson MR, Cirillo JD, Olaleye O, Endsley JJ. In vitro model of mycobacteria and HIV-1 co-infection for drug discovery. Tuberculosis (Edinb). 2013 Dec; 93 Suppl:S66-70.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support